Aifen X. Liu

Nantong, 226001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives.

Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives.

Journal: Nutrients

Published: January 12, 2026

Formononetin alleviates ovarian fibrosis and inflammation via targeting SOCS3 and inhibiting TGF-β1/Smad signaling in PCOS.

Formononetin alleviates ovarian fibrosis and inflammation via targeting SOCS3 and inhibiting TGF-β1/Smad signaling in PCOS.

Journal: Chinese herbal medicines

Published: October 31, 2025

Artemisinin and Its Derivatives from Molecular Mechanisms to Clinical Applications: New Horizons Beyond Antimalarials.

Artemisinin and Its Derivatives from Molecular Mechanisms to Clinical Applications: New Horizons Beyond Antimalarials.

Journal: International journal of molecular sciences

Published: July 21, 2025

Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma.

Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma.

Journal: European journal of pharmacology

Published: October 22, 2023

Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives.

Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives.

Journal: Current neuropharmacology

Published: August 22, 2022

Progress of correlation study between gut microbiome and polycystic ovary syndrome

Progress of correlation study between gut microbiome and polycystic ovary syndrome

Journal: Zhonghua fu chan ke za zhi

Published: April 07, 2022

Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.

Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.

Journal: Tumori

Published: June 24, 2021

Long-Term Protection of CHBP Against Combinational Renal Injury Induced by Both Ischemia-Reperfusion and Cyclosporine A in Mice.

Long-Term Protection of CHBP Against Combinational Renal Injury Induced by Both Ischemia-Reperfusion and Cyclosporine A in Mice.

Journal: Frontiers in immunology

Published: April 20, 2021

A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2.

A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2.

Journal: Cell reports

Published: July 30, 2020

Potent Therapy and Transcriptional Profile of Combined Erythropoietin-Derived Peptide Cyclic Helix B Surface Peptide and Caspase-3 siRNA against Kidney Ischemia/Reperfusion Injury in Mice.

Potent Therapy and Transcriptional Profile of Combined Erythropoietin-Derived Peptide Cyclic Helix B Surface Peptide and Caspase-3 siRNA against Kidney Ischemia/Reperfusion Injury in Mice.

Journal: The Journal of pharmacology and experimental therapeutics

Published: May 08, 2020

Multi-omics analysis reveals the functional transcription and potential translation of enhancers.

Multi-omics analysis reveals the functional transcription and potential translation of enhancers.

Journal: International journal of cancer

Published: January 28, 2020

Erythropoietin Derived Peptide Improved Endoplasmic Reticulum Stress and Ischemia-Reperfusion Related Cellular and Renal Injury.

Erythropoietin Derived Peptide Improved Endoplasmic Reticulum Stress and Ischemia-Reperfusion Related Cellular and Renal Injury.

Journal: Frontiers in medicine

Published: November 01, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026